地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18995651644
传真:13212737804
邮箱:sales@amyjet.com

Innovative Research of America(IRA) 是一家致力研发于药物定量定时缓释系统的专业化公司,又称Matrix-Driven Delivery (MDD) 给药系统。该给药系统由一个可生物吸收的基质组成,含有定量可控的活性给药成分,可以以设定的剂量在一定时间范围内进行给药。
Since it is not easy to administer drugs and hormones orally to research animals, several delivery methods have been devised as alternatives. However, most scientists continue to labor with unreliable injectables to conduct their research.
Matrix-Driven Delivery (MDD) Pellet(MDD片剂)的优势
Saves time
Ready-to-implant
Insures controlled product release over time
Avoids "peak and valley" effects
Guarantees consistent product preparation
Extends product life against spontaneous breakdown
Extends product life against host-related breakdown
Minimizes experimental variables
Insures safety of the experimenter
Reduces neurophysiological trauma to animal/no excessive handling
Generates more meaningful and reproducible results
Superior to conventional delivery methods
Enhances experimental efficiency
Frees valuable time for creative research
Saves money
Innovative Research of America的主要产品包括:
ANTIBIOTICS
ANTI-INFLAMMATORY AGENTS
ANTI-NEOPLASTICS
CATECHOLAMINES & RELATED PRODUCTS
CORTICOIDS & DIURETICS
ESTROGENS & ANTI-ESTROGENS
FATTY ACIDS
MISCELLANEOUS PRODUCTS
NUCLEOTIDE RELATED PRODUCTS
PLACEBO
PROGESTINS
PROSTAGLANDINS
THYROIDS
VITAMINS
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://atto.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Innovative Research of America"> Innovative Research of America
invivoCrown IV0113替换BioXCell BE0075
invivoCrown IV0119替换BioXCell BE0004-1
invivoCrown IV0120替换BioXCell BE0015-1

艾美捷科技代理Schircks Laboratories品牌。
瑞士Schircks Laboratories由B.Schircks博士于1980年创立,主要生产蝶啶及蝶啶类化合物(Pteridines)。至今,Schircks实验室合成了100多种蝶啶类化合物,主要用于科学研究和临床诊断应用。产品包括:
<| 11.180 | 6-(L-1,2,3-Trihydroxybutyl)-pterin [Rhamnopterin] |
| 11.182 | (6R,S)-5,6,7,8-Tetrahydro-L-rhamnopterin dihydrochloride |
| 11.203 | L-Biopterin [L-erythro-Biopterin] |
| 11.206 | 7,8-Dihydro-L-biopterin |
| 11.209 | (6R,S)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride |
| 11.212 | (6R)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride |
| 11.213 | (6R)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride |
| 11.215 | (6S)-5,6,7,8-Tetrahydro-L-biopterin sulfate |
| 11.216 | (6S)-5,6,7,8-Tetrahydro-L-biopterin sulfate |
| 11.217 | (6R)-5-Methyl-5,6,7,8-tetrahydro-L-biopterin dihydrochloride |
| 11.218 | D-Biopterin [D-erythro-Biopterin] |
| 11.220 | (6R,S)-5,6,7,8-Tetrahydro-D-biopterin dihydrochloride |
| 11.221 | D-threo-Biopterin [Dictyopterin] |
| 11.223 | (6R,S)-5,6,7,8-Tetrahydro-D-threo-biopterin dihydrochloride |
| 11.228 | Deoxysepiapterin |
| 11.229 | 6-((1R,S)-Hydroxypropyl)pterin [(1'R,S)-2'-Deoxybiopterin] |
| 11.231 | 7-Biopterin |
| 11.234 | 7-Tetrahydro-L-biopterin dihydrochloride |
| 11.260 | Oncopterin |
| 11.270 | 4-Hydroxy-6-(L-erythro-1,2-dihydroxy-propyl)-2-(methylthio)pteridine |
| 11.280 | 4-Amino-L-biopterin [2,4-Diamino-6-(L-erythro-1',2'-dihydroxypropyl)pteridine] |
| 11.282 | 4-Amino-(6R,S)-5,6,7,8-tetrahydro-L-biopterin dihydrochloride |
| 11.283 | 4-Amino-(6R)-5,6,7,8-tetrahydro-L-biopterin dihydrochloride |
| 11.303 | D-Neopterin [D-erythro-Neopterin] |
| 11.306 | 7,8-Dihydro-D-neopterin |
| 11.307 | 7,8-Dihydro-D-neopterin-3’-triphosphate (Please refer to our reference 8) |
| 11.309 | (6R,S)-5,6,7,8-Tetrahydro-D-neopterin dihydrochloride |
| 11.314 | D-Neopterin-3’-monophosphate, lithium salt |
| 11.315 | 7,8-Dihydro-D-neopterin-3’-monophosphate, lithium salt |
| 11.320 | 3'-Hydroxy-D-sepiapterin |
| 11.330 | 7-Neopterin |
| 11.340 | L-Monapterin [L-threo-Neopterin] |
| 11.345 | 7,8-Dihydro-L-monapterin |
| 11.346 | (6R,S)-5,6,7,8-Tetrahydro-L-monapterin dihydrochloride |
| 11.349 | D-Monapterin [D-threo-Neopterin] |
| 11.403 | Pterin-6-carboxylic acid |
| 11.409 | Pterin-7-carboxylic acid |
| 11.415 | 6-Formylpterin [Pterin-6-aldehyde] |
| 11.416 | 6-Formyl-7,8-dihydropterin |
| 11.418 | Acetyl-6-formylpterin |
| 11.420 | 6-Hydroxymethylpterin |
| 11.421 | 6-Hydroxymethyl-7,8-dihydropterin hydrochloride |
| 11.422 | 6-Hydroxymethyl-7,8-dihydropterin-diphosphate (Please refer to our reference 8) |
| 11.423 | (6R,S)-6-Hydroxymethyl-5,6,7,8-tetrahydropterin dihydrochloride |
| 11.429 | 6-Hydroxymethylpterin-monophosphate |
| 11.438 | 6-Hydroxymethylpterin-diphosphate, lithium salt |
| 11.480 | 6-Methylpterin |
| 11.481 | 6-Methyl-7,8-dihydropterin hydrochloride |
| 11.483 | (6R,S)-6-Methyl-5,6,7,8-tetrahydropterin dihydrochloride |
| 11.503 | 6,7-Dimethylpterin |
| 11.506 | 6,7-Dimethyl-7,8-dihydropterin monohydrochloride |
| 11.509 | 6,7-Dimethyl-5,6,7,8-tetrahydropterin monohydrochloride |
| 11.703 | Leucopterin |
| 11.713 | Xanthopterin |
| 11.716 | Dihydroxanthopterin |
| 11.723 | Isoxanthopterin |
| 11.903 | Pterin |
| 11.906 | 7,8-Dihydropterin (Please refer to our reference 20) |
| 11.909 | 5,6,7,8-Tetrahydropterin dihydrochloride |
| 13.103 | Lumazine |
| 13.203 | 6-Hydroxylumazine |
| 13.206 | 6-Hydroxy-7,8-dihydrolumazine |
| 13.220 | 7-Hydroxylumazine |
| 16.113 | Pteroic acid |
| 16.123 | N10-(Trifluoroacetyl)pteroic acid |
| 16.140 | 10-Formylpteroic acid |
| 16.203 | Folic acid |
| 16.206 | 7,8-Dihydrofolic acid |
| 16.208 | (6S)-5,6,7,8-Tetrahydrofolic acid trihydrochloride |
| 16.209 | (6R,S)-5,6,7,8-Tetrahydrofolic acid trihydrochloride |
| 16.211 | 10-Methylfolic acid |
| 16.215 | 10-Formylfolic acid |
| 16.217 | 10-Formyl-5,6,7,8-tetrahydrofolic acid (Please refer to our reference 19) |
| 16.220 | (6R,S)-5-Formyl-5,6,7,8-tetrahydrofolic acid, calcium salt |
| 16.222 | (6R)-5-Formyl-5,6,7,8-tetrahydrofolic acid, calcium salt (unnatural calcium folinate) |
| 16.230 | (6R,S)-5,10-Methenyl-5,6,7,8-tetrahydrofolic acid chloride |
| 16.233 | (6R,S)-5-Methyl-5,6-dihydrofolic acid, ammonium salt |
| 16.235 | (6R,S)-5-Methyl-5,6,7,8-tetrahydrofolic acid, calcium salt |
| 16.236 | (6S)-5-Methyl-5,6,7,8-tetrahydrofolic acid, calcium salt |
| 16.243 | (6R,S)-5-Methyl-5,6,7,8-tetrahydropteroyltri-γ-L-glutamic acid trihydrochloride |
| 16.244 | (6R,S)-5-Methyl-5,6,7,8-tetrahydropteroyltetra-γ-L-glutamic acid trihydrochloride |
| 16.252 | Pteroyldi-γ-L-glutamic acid |
| 16.253 | Pteroyltri-γ-L-glutamic acid has been discontinued |
| 16.254 | Pteroyltetra-γ-L-glutamic acid |
| 16.255 | Pteroylpenta-γ-L-glutamic acid has been discontinued |
| 16.266 | Pteroylhexa-γ-L-glutamic acid, ammonium salt |
| 16.267 | Pteroylhepta-γ-L-glutamic acid, ammonium salt |
| 16.280 | (6R,S)-5-Formyl-5,6,7,8-tetrahydropteroic acid |
| 16.282 | (6R,S)-5-Formyl-5,6,7,8-tetrahydropteroyldi-γ-L-glutamic acid, lithium salt has been discontinued |
| 16.283 | (6R,S)-5-Formyl-5,6,7,8-tetrahydropteroyltri-γ-L-glutamic acid, lithium salt has been discontinued |
| 16.284 | (6R,S)-5-Formyl-5,6,7,8-tetrahydropteroyltetra-γ-L-glutamic acid, lithium salt |
| 16.285 | (6R,S)-5-Formyl-5,6,7,8-tetrahydropteroylpenta-γ-L-glutamic acid, lithium salt |
| 16.286 | (6R,S)-5-Formyl-5,6,7,8-tetrahydropteroylhexa-γ-L-glutamic acid, lithium salt |
| 16.330 | Aminopterin [4-Aminofolic acid] |
| 16.403 | 4-Amino-10-methylpteroic acid (APA, DAMPA) |
| 16.411 | Methotrexate [4-Amino-10-methylpteroyl-γ-L-glutamic acid] |
| 16.412 | 4-Amino-10-methylpteroyldi-γ-L-glutamic acid, ammonium salt [Methotrexate diglutamate] |
| 16.413 | 4-Amino-10-methylpteroyltri-γ-L-glutamic acid, ammonium salt [Methotrexate triglutamate] |
| 16.414 | 4-Amino-10-methylpteroyltetra-γ-L-glutamic acid, ammonium salt [Methotrexate tetraglutamate] |
| 16.415 | 4-Amino-10-methylpteroylpenta-γ-L-glutamic acid, ammonium salt [Methotrexate pentaglutamate] |
| 16.416 | 4-Amino-10-methylpteroylhexa-γ-L-glutamic acid, ammonium salt [Methotrexate hexaglutamate] |
| 16.417 | 4-Amino-10-methylpteroylhepta-γ-L-glutamic acid, ammonium salt [Methotrexate heptaglutamate] |
| 16.500 | 7-Hydroxymethotrexate |
| 16.701 | p-Aminobenzoyl-L-glutamic acid |
| 16.702 | p-Aminobenzoyldi-γ-L-glutamic acid, ammonium salt |
| 16.703 | p-Aminobenzoyltri-γ-L-glutamic acid, ammonium salt |
| 16.704 | p-Aminobenzoyltetra-γ-L-glutamic acid, ammonium salt |
| 16.705 | p-Aminobenzoylpenta-γ-L-glutamic acid, ammonium salt |
| 16.706 | p-Aminobenzoylhexa-γ-L-glutamic acid, ammonium salt |
| 16.707 | p-Aminobenzoylhepta-γ-L-glutamic acid, ammonium salt has been discontinued |
| 16.901 | Z-Glu-OtBu |
| 16.902 | Z-Glu2-OtBu3 |
| 16.903 | Z-Glu3-OtBu4 |
| 16.904 | Z-Glu4-OtBu5 |
| 16.905 | Z-Glu5-OtBu6 |
| 16.906 | Z-Glu6-OtBu7 |
| 91.303 | D-(5-15N)-Neopterin |
| 96.203 | (5-15N)-Folic acid |
invivoCrown IV0101替换BioXCell BE0101
invivoCrown IV0116替换BioXCell BE0016-2

艾美捷科技代理Quartett品牌
Quartett公司于1986年在德国柏林创立,始终致力于癌症防治领域并推动肿瘤诊断技术革新。quartett专注于两大核心业务:为解剖病理学/免疫组化(IHC)领域生产单克隆抗体,同时为制药工业及科研机构提供合成多肽产品。
▍Quartett两大核心技术
● 兔源重组单克隆抗体技术平台:突破传统鼠源抗体的局限。相较于鼠类免疫系统,兔源免疫系统具有显著优势——可识别更微小表位(≤5个氨基酸)、产生亲和力达10⁻¹²M的高特异性抗体,这使得quartett公司开发的诊断试剂在癌症检测中展现出卓越性能(如PD-L1检测灵敏度92.7%)。
● 合成肽制备技术:专业生产HPLC纯度>95%的定制肽,包括蛋白酶抑制剂及抗体生产用免疫原肽。该平台的成功更直接推动了兔源重组抗体技术的突破性发展,形成从合成肽到高价值诊断抗体的完整技术闭环。所有试剂均优化适配全自动染色平台(如Roche Ventana/Leica BOND)及人工染色流程。

▍Quartett部分产品列表
| 品名 | 货号 | Application | Host | Subclass | 规格 |
| CD31 (QR034) | C-C031-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| ERG (QR040) | C-E003-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Arginase-1 (QR083) | C-A003-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Cadherin 17(QR098) | C-C036-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| CD117 (QR012) | P-C003-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| CD171/L1CAM (QR039) | C-C025-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| CDX2 (QR045) | P-C016-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| Cytokeratin 20 (Ks20.8) | C-C005-01 | IHC (FFPE) | Mouse | IgG2a/k | 0.1 ml concentrate |
| Glutamine synthetase (QR090) | P-G003-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| Glypican 3 (QR103) | C-G005-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| HSP70 (QR087) | P-H002-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| MLH1 (QM003) | C-M001-01 | IHC (FFPE) | Mouse | IgG2a/IgK | 0.1 ml concentrate |
| MSH2 (QR010) | P-M004-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| MSH6 (QR011) | C-M005-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| PMS2 (QR009) | P-P005-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| SATB2 (QR023) | C-S002-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| SMAD4 (QR029) | P-S007-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| BAP1 (QR119) | C-B005-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Cytokeratin 14 (QR057) | P-C033-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| Cytokeratin 5 (QR027) | C-C008-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Cytokeratin 5/14 (QR027/QR057) | P-C035-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| Cytokeratin 5/6 (QR027/QR028) | C-C017-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Cytokeratin 6 (QR028) | C-C009-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Cytokeratin 7 (QR049) | P-C014-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| Cytokeratin 8 (QR112) | C-C040-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Cytokeratin pan (MNF-116) | P-C034-150 | IHC (FFPE) | Mouse | IgG1/k | 15 ml Ready to use |
| EpCAM (QR107) | C-E006-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| GLUT1 (QR082) | P-G004-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| Inhibin alpha (QR088) | C-I004-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| NUT (QR043) | P-N001-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| p21 (QR085) | C-P017-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| p53 (QR025) | P-P011-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
invivoCrown IV0114替换BioXCell BE0213
地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18995651644
传真:13212737804
邮箱:sales@amyjet.com
0.1266